CTRI/2021/10/037378
Completed
Phase 2
A Study To Assess Efficacy And Safety Of Polyherbal Formulation (COVI-RB01) As An Add-On Therapy With Standard of Care In Mild And Moderate Covid-19 Positive Patients - COVI-RB01
Alakart Bio Pharma Pvt Ltd0 sites130 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Sponsor
- Alakart Bio Pharma Pvt Ltd
- Enrollment
- 130
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •RT\-PCR based diagnosis of COVID\-19
- •\- Treatment trials: cases of mild and moderate severity.
- •\- Willingness to participate.
Exclusion Criteria
- •\- Severe category (Spo2 \< 90\).
- •\- Individuals with uncontrolled, unstable co\-morbidities.
- •\- Individuals with pre\-existing respiratory conditions. Immuno\-compromised individuals or those on immuno\-suppressants.
- •\- Pregnant and lactating females.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Clinical Study to Evaluate the Effect of Polyherbal Unani formulations in Waram-e-lawzatayn Muzmin (Chronic Tonsillitis).CTRI/2023/09/057524Ministry of Ayush UP
Recruiting
Phase 2
Clinical Study To Evaluate the efficacy of polyherbal Unani formulation in Zukam (Coryza OR Common Cold)CTRI/2023/08/056975State Unani Medical College
Recruiting
Phase 3
CLINICAL RESEARCH ON SIDDHA MEDICINE IN IYA ERAIPPU NOI(BRONCHIAL ASTHMA)CTRI/2013/12/004253AYOTHIDOSS PANDITHAR HOSPITA125
Not yet recruiting
Phase 2
To Asses efficacy and safety of polyherbal unani formulation In NazlaCTRI/2023/10/058727State Unani Medical College Himmatganj Prayagraj
Not yet recruiting
Phase 2
Evaluation of efficacy and safety of Polyherbal Unani formulations in the management of EczemaCTRI/2024/02/062979Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush